Evidence map›Paper›PMID 32241850›Full record

ReviewHaematologica2020

Clinical practice recommendation on hematopoietic stem cell transplantation for acute myeloid leukemia patients with

Ali Bazarbachi, Gesine Bug, Frederic Baron, Eolia Brissot, Fabio Ciceri, Iman Abou Dalle, Hartmut Döhner, Jordi Esteve, Yngvar Floisand, Sebastian Giebel and 22 more

Open access · goldAbstract readReviewConsensus Statement
PubMed Full text at PMC Publisher
In one paragraph

Review in Haematologica, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 87 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
87citing papers in PubMed, 6 pooled it
11.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

87 citing papers in PubMed, 6 syntheses or guidelines pooled it, 135 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review

27 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors at 20 institutions in 15 countries.

Ali BazarbachiBone Marrow Transplantation Program, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon bazarbac@aub.edu.lb.
Gesine BugDepartment of Medicine 2, Hematology and Oncology, University Hospital, Goethe University Frankfurt, Frankfurt am Main, Germany.
Frederic BaronGIGA-I3, University and CHU of Liège, Liège, Belgium.
Eolia BrissotSorbonne Universités, UPMC University of Paris 06, INSERM, Centre de Recherche Saint-Antoine (CRSA), Hematology Department, AP-HP, Saint Antoine Hospital, Paris, France.
Fabio CiceriVita-Salute San Raffaele University of Milan, Milan, ItalyHematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Iman Abou DalleBone Marrow Transplantation Program, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Hartmut DöhnerDepartment of Internal Medicine III, Ulm University Hospital, Ulm, Germany.
Jordi EsteveHematology Department, Hospital Clínic of Barcelona, IDIBAPS, University of Barcelona, Barcellona, Spain.
Yngvar FloisandDepartment of Hematology, Oslo University Hospital - Rikshospitalet, Oslo, Norway.
Sebastian GiebelDepartment of Bone Marrow Transplantation and Oncohematology, Maria Sklodowska-Curie Institute - Oncology Center, Gliwice Branch, Gliwice, Poland.
Maria GilleeceDepartment of Haematology, Leeds Teaching Hospitals Trust, Leeds, UK.
Norbert-Claude GorinDepartment of Hematology and Cell Therapy, European Society for Blood and Marrow Transplantation, Paris Office, Hopital Saint-Antoine, Paris, France.
Elias JabbourDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Mahmoud AljurfDepartment of Hematology King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia.
Hagop KantarjianDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Mohamed Kharfan-DabajaDivision of Hematology-Oncology and Blood and Marrow Transplantation and Cellular Therapies Program, Mayo Clinic, Jacksonville, FL, USA.
Myriam LabopinAcute Leukemia Working Party, Paris Study Office, European Society for Blood and Marrow Transplantation, Paris, France.
Francesco LanzaRomagna Transplant Network, Ravenna, Italy.
Florent MalardSorbonne Universités, UPMC University of Paris 06, INSERM, Centre de Recherche Saint-Antoine (CRSA), Hematology Department, AP-HP, Saint Antoine Hospital, Paris, France.
Zinaida PericUniversity Hospital Center Zagreb, School of Medicine, University of Zagreb, Zagreb, Croatia.
Thomas PrebetSection of Hematology, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA.
Farhad RavandiDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Annalisa RuggeriDepartment of Pediatric Hematology and Oncology, IRCCS Bambino Gesù Children's Hospital, Roma, ItalyEurocord, Hôpital Saint Louis, Paris, France.
Jaime SanzHematology Department, Hospital Universitari i Politecnic La Fe. Instituto de Investigación Sanitaria La Fe, Valencia, CIBERONC, Instituto Carlos III, Madrid, Spain.
Christoph SchmidDepartment of Hematology and Oncology, Augsburg University Hospital, Augsburg, Germany.
Roni ShouvalAdult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Alexandros SpyridonidisBMT Unit, University of Patras, Patras, Greece.
Jurjen VersluisErasmus University Medical Center Cancer Institute, Rotterdam, the Netherlands.
Norbert VeyDepartment of Hematology, Institut Paoli-Calmettes, Marseille, France.
Bipin N SavaniDepartment of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, TN, USA.
Arnon NaglerHematology and Bone Marrow Transplantation Division, Chaim Sheba Medical Center, Tel-Hashomer, Sackler School of Medicine, Tel Aviv University, Israel.
Mohamad MohtySorbonne Universités, UPMC University of Paris 06, INSERM, Centre de Recherche Saint-Antoine (CRSA), Hematology Department, AP-HP, Saint Antoine Hospital, Paris, France.
The University of Texas MD Anderson Cancer Center · USCentre de Recherche Saint-Antoine · FRAmerican University of Beirut · LBAmerican University of Beirut Medical Center · LBAssistance Publique – Hôpitaux de Paris · FRAzienda Unità Sanitaria Locale Della Romagna · ITCentro de Investigación Biomédica en Red de Cáncer · ESConsorci Institut D'Investigacions Biomediques August Pi I Sunyer · ESErasmus MC · NLGoethe University Frankfurt · DEHôpital Saint-Antoine · FRHôpital Saint-Louis · FRInstitut Paoli-Calmettes · FRIstituti di Ricovero e Cura a Carattere Scientifico · ITKing Faisal Specialist Hospital & Research Centre · SALeeds Teaching Hospitals NHS Trust · GBMayo Clinic in Florida · USMemorial Sloan Kettering Cancer Center · USOslo University Hospital · NOSorbonne Université · FR

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
NCATS NIH HHS UL1 TR001863
6 · The paper itself

Abstract

The

Indexed as

Hematopoietic Stem Cell TransplantationLeukemia, Myeloid, AcuteBone Marrowfms-Like Tyrosine Kinase 3HumansRemission InductionFLT3 protein, humanfms-Like Tyrosine Kinase 3

Identifiers

PMID32241850
PMCPMC7271578
OpenAlexW3014928753

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.